newsTaro Pharmaceuticals voluntarily recalls one lot of lamotrigine tablets13 January 2020 | By Victoria Rees (European Pharmaceutical Review)Due to cross-contamination with enalapril maleate, Taro is voluntarily recalling one lot of its lamotrigine tablets at the consumer level.